WallStreetZenWallStreetZen

NASDAQ: AHCO
Adapthealth Corp Stock

$21.19-0.06 (-0.28%)
Updated Jan 27, 2023
AHCO Price
$21.19
Fair Value Price
$22.05
Market Cap
$2.85B
52 Week Low
$11.40
52 Week High
$27.48
P/E
32.6x
P/B
1.33x
P/S
0.87x
PEG
0.65x
Dividend Yield
N/A
Revenue
$2.89B
Earnings
$94.85M
Gross Margin
15.5%
Operating Margin
7.93%
Profit Margin
3.3%
Debt to Equity
1.43
Operating Cash Flow
$378M
Beta
0.57
Next Earnings
Feb 22, 2023
Ex-Dividend
N/A
Next Dividend
N/A

AHCO Overview

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AHCO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AHCO ($21.19) is undervalued by 3.92% relative to our estimate of its Fair Value price of $22.05 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AHCO ($21.19) is not significantly undervalued (3.92%) relative to our estimate of its Fair Value price of $22.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AHCO ($21.19) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AHCO due diligence checks available for Premium users.

Be the first to know about important AHCO news, forecast changes, insider trades & much more!

AHCO News

Valuation

AHCO fair value

Fair Value of AHCO stock based on Discounted Cash Flow (DCF)
Price
$21.19
Fair Value
$22.05
Undervalued by
3.92%
AHCO ($21.19) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AHCO ($21.19) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AHCO ($21.19) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AHCO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
32.6x
Industry
57.58x
Market
23.59x
AHCO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AHCO is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

AHCO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.33x
Industry
3.56x
AHCO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AHCO price to earnings growth (PEG)

For valuing profitable companies with growth potential
AHCO is good value based... subscribe to Premium to read more.
PEG Value Valuation

AHCO's financial health

Profit margin

Revenue
$756.5M
Net Income
$16.1M
Profit Margin
2.1%
AHCO's Earnings (EBIT) of $229.42M... subscribe to Premium to read more.
Interest Coverage Financials
AHCO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.2B
Liabilities
$3.1B
Debt to equity
1.43
AHCO's short-term assets ($631.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AHCO's long-term liabilities ($2.61B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AHCO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$107.0M
Investing
-$95.3M
Financing
-$19.7M
AHCO's operating cash flow ($377.88M)... subscribe to Premium to read more.
Debt Coverage Financials

AHCO vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
AHCO$2.85B-0.28%32.60x1.33x
INMD$2.92B+1.60%16.66x5.75x
CNMD$2.92B-0.22%-34.26x4.08x
LIVN$2.96B-0.75%-31.41x2.58x
AXNX$3.09B-0.32%-38.09x5.63x

Adapthealth Stock FAQ

What is Adapthealth's quote symbol?

NASDAQ: AHCO) Adapthealth trades on the NASDAQ under the ticker symbol AHCO. Adapthealth stock quotes can also be displayed as NASDAQ: AHCO.

If you're new to stock investing, here's how to buy Adapthealth stock.

What is the 52 week high and low for Adapthealth (NASDAQ: AHCO)?

(NASDAQ: AHCO) Adapthealth's 52-week high was $27.48, and its 52-week low was $11.40. It is currently -22.89% from its 52-week high and 85.88% from its 52-week low.

How much is Adapthealth stock worth today?

(NASDAQ: AHCO) Adapthealth currently has 134,731,665 outstanding shares. With Adapthealth stock trading at $21.19 per share, the total value of Adapthealth stock (market capitalization) is $2.85B.

Adapthealth stock was originally listed at a price of $10.00 in Feb 16, 2018. If you had invested in Adapthealth stock at $10.00, your return over the last 4 years would have been 111.9%, for an annualized return of 20.65% (not including any dividends or dividend reinvestments).

How much is Adapthealth's stock price per share?

(NASDAQ: AHCO) Adapthealth stock price per share is $21.19 today (as of Jan 27, 2023).

What is Adapthealth's Market Cap?

(NASDAQ: AHCO) Adapthealth's market cap is $2.85B, as of Jan 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Adapthealth's market cap is calculated by multiplying AHCO's current stock price of $21.19 by AHCO's total outstanding shares of 134,731,665.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.